Company intelligence / Profile preview

Kare & Hope

Canada

Ownership: Private
Development stage: Other

Overview

Kare & Hope offers natural health supplements based on black seed (Nigella sativa) and other botanicals, with claims of supporting immune function, reducing inflammation, and promoting general wellness; the products are available over the counter and are not drugs subjected to clinical trial data or regulatory approval as pharmaceuticals.

Therapeutic areas: ImmunologyRheumatologyPsychiatryMen's HealthPulmonologyCardiovascularNeurology
Modalities: Natural supplementHerbal product
Industry: Food & Nutrition

Beyond the preview

Go deeper on Kare & Hope.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kare & Hope.

Explore the full profile